201. Crimean–Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway
- Author
-
Aura R. Garrison, Gianluca Pegoraro, Gordon Ruthel, Sina Bavari, Krishna P. Kota, Louis A. Altamura, Connie S. Schmaljohn, Jens H. Kuhn, Steven A. Kwilas, Sheli R. Radoshitzky, and Volker Haucke
- Subjects
Crimean–Congo hemorrhagic fever ,Endosome ,Adaptor Protein Complex 2 ,Endocytosis ,Clathrin ,Virus entry ,Viral entry ,Virology ,CCHF ,medicine ,Humans ,rab5 GTP-Binding Proteins ,Nairovirus ,biology ,Early endosome ,rab7 GTP-Binding Proteins ,Clathrin-Coated Vesicles ,Hydrogen-Ion Concentration ,Virus Internalization ,biology.organism_classification ,medicine.disease ,rab GTP-Binding Proteins ,Hemorrhagic Fever Virus, Crimean-Congo ,biology.protein ,Bunyavirus ,Crimean Congo hemorrhagic fever virus - Abstract
The early events in Crimean–Congo hemorrhagic fever virus (CCHFV) have not been completely characterized. Earlier work indicated that CCHFV likely enters cells by clathrin-mediated endocytosis (CME). Here we provide confirmatory evidence for CME entry by showing that CCHFV infection is inhibited in cells treated with Pitstop 2, a drug that specifically and reversibly interferes with the dynamics of clathrin-coated pits. Additionally, we show that CCHFV infection is inhibited by siRNA depletion of the clathrin pit associated protein AP-2. Following CME entry, we show that CCHFV has a pH-dependent entry step, with virus inactivation occurring at pH 6.0 and below. To more precisely define the endosomal trafficking of CCHFV, we show for the first time that overexpression of the dominant negative forms of Rab5 protein but not Rab7 protein inhibits CCHFV infection. These results indicate that CCHFV likely enters cells through the early endosomal compartment.
- Published
- 2013